Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)
Status:
Unknown status
Trial end date:
2021-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of conversion to TacroBell
slow-release cap.(Once-daily Tacrolimus) in patients undergoing maintenance therapy with
Twice-Daily Tacrolimus after liver transplantation.